Before determining the genetic effects of APOE and NR1H3 gene variations in the brain, we first performed biochemical assessment of the brain sample set consisting of inferior temporal cortex samples from 87 subjects with neuropathologically well-defined AD neurofibrillary changes (Table 1). Here, NR1H3 is linked to Alzheimer disease.